Abide Therapeutics, based in Princeton, NJ, is a science-based organization dedicated to researching and developing transformative medicines for brain diseases. Their focus areas include neurology, psychiatry, and sustainability, with a commitment to community engagement and diversity.
Driven by their core value of research and development, Abide Therapeutics collaborates with partners worldwide to discover new pharmaceuticals targeting the underlying mechanisms of brain diseases. Their pipeline reflects a goal to deliver novel therapies that redefine the standard of care for patients in need.
Generated from the website